Randomised double-blind placebo-controlled intervention study on the nutritional efficacy of a food for special medical purposes (FSMP) and a dietary supplement in reducing the symptoms of veisalgia.
nutritional treatment
Journal
BMJ nutrition, prevention & health
ISSN: 2516-5542
Titre abrégé: BMJ Nutr Prev Health
Pays: England
ID NLM: 101769223
Informations de publication
Date de publication:
2020
2020
Historique:
received:
28
06
2019
revised:
28
02
2020
accepted:
07
03
2020
entrez:
25
11
2020
pubmed:
26
11
2020
medline:
26
11
2020
Statut:
epublish
Résumé
To assess whether the symptoms of veisalgia can be reduced by intense water supply and the intake of antioxidative supplements and plant extracts. We performed the world's largest randomised double-blind placebo-controlled intervention study (214 participants) on the efficacy of a food for special medical purposes (FSMP) against veisalgia symptoms. We analysed the effectiveness of: (1) an FSMP, including distinct plant extracts, vitamins and minerals, and additional (antioxidative) compounds; (2) a dietary supplement only comprising vitamins and minerals and additional (antioxidative) compounds; and (3) a placebo containing only glucose. The study followed the CONSORT (Consolidated Standards of Reporting Trials) guidelines and trial registration was not necessary. Our study showed no statistically significant relationship between the variation of body water content and alcohol consumption. Contrary to common belief, the results showed that intervention with a supplement containing vitamins and minerals and additional antioxidative compounds did not lead to a statistically significant improvement in hangover symptoms. Additionally, our results confirmed a high individual variability in developing hangover symptoms depending on the amount of alcohol. Thus, standardisation of the amount of alcohol consumed in hangover studies does not necessarily contribute to the validity of the results. Finally, this study found a number of positive effects on certain hangover symptoms as a result of the FSMP, which were most likely due to the plant extracts contained within the food. This study significantly supports the finding that haemostasis of electrolytes and minerals caused by alcohol consumption might be negligible and that no significant dehydration due to alcohol consumption seems to occur. Additionally, only the FSMP provides evidence for a significant efficiency in the reduction of hangover symptoms such as headache and nausea following moderate and non-excessive alcohol consumption.
Identifiants
pubmed: 33235969
doi: 10.1136/bmjnph-2019-000042
pii: bmjnph-2019-000042
pmc: PMC7664490
doi:
Types de publication
Journal Article
Langues
eng
Pagination
31-39Informations de copyright
© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
Alcohol Clin Exp Res. 2003 Sep;27(9):1442-50
pubmed: 14506405
Alcohol Alcohol. 2008 Mar-Apr;43(2):163-70
pubmed: 18238851
Mech Ageing Dev. 1990 Feb 15;51(3):283-97
pubmed: 2308398
Neuroscience. 2015 Sep 24;304:47-59
pubmed: 26192095
J Food Sci. 2014 Jul;79(7):C1323-30
pubmed: 24962619
Hum Psychopharmacol. 2009 Jun;24(4):259-67
pubmed: 19347842
Skin Pharmacol Physiol. 2013;26(1):45-51
pubmed: 23147451
Biomed Pharmacother. 2016 Dec;84:698-704
pubmed: 27710894
Sci Rep. 2016 Sep 14;6:32554
pubmed: 27624556
Lancet. 2002 Feb 9;359(9305):515-9
pubmed: 11853818
BMJ. 2005 Dec 24;331(7531):1515-8
pubmed: 16373736
Alcohol Alcohol. 2012 May-Jun;47(3):248-52
pubmed: 22434663
Curr Drug Abuse Rev. 2017;9(2):148-154
pubmed: 28215179
Indian J Clin Biochem. 2005 Jan;20(1):80-4
pubmed: 23105499
J Integr Med. 2014 Jan;12(1):59-65
pubmed: 24461596
Curr Drug Abuse Rev. 2010 Jun;3(2):68-75
pubmed: 20712596
Arch Intern Med. 2004 Jun 28;164(12):1334-40
pubmed: 15226168
J Biomed Res. 2017 Nov 01;:
pubmed: 29089471
Pharmazie. 2007 Apr;62(4):299-304
pubmed: 17484288
Curr Drug Abuse Rev. 2010 Jun;3(2):76-9
pubmed: 20712591
Indian J Exp Biol. 2010 Feb;48(2):143-9
pubmed: 20455323
Toxicology. 2011 Sep 5;287(1-3):124-30
pubmed: 21704112
J Ethnopharmacol. 2018 Jun 28;220:147-154
pubmed: 29626671
Control Clin Trials. 1996 Feb;17(1):1-12
pubmed: 8721797
Eur J Clin Invest. 1976 Jan 30;6(1):93-102
pubmed: 1253812
Curr Drug Abuse Rev. 2010 Jun;3(2):116-26
pubmed: 20712593
Novartis Found Symp. 2007;285:23-40; discussion 40-51, 198-9
pubmed: 17590985
J Food Sci. 2009 Sep;74(7):H204-8
pubmed: 19895471
Curr Opin Clin Nutr Metab Care. 2008 Jan;11(1):21-6
pubmed: 18090653
Planta Med. 2006 Nov;72(14):1296-9
pubmed: 17022004
J Clin Biochem Nutr. 2011 May;48(3):214-21
pubmed: 21562641
CMAJ. 2003 Dec 9;169(12):1269-73
pubmed: 14662662
Adv Pharmacol. 1997;38:601-28
pubmed: 8895826
Ann Intern Med. 2000 Jun 6;132(11):897-902
pubmed: 10836917
Alcohol Res. 2013;35(1):6-16
pubmed: 24313160
Alcohol Clin Exp Res. 2006 Sep;30(9):1500-5
pubmed: 16930212
Addict Behav. 2007 Jun;32(6):1314-20
pubmed: 17097819